Trend Screener

Glenmark Pharmaceuticals Share Price GLENMARK

Glenmark Pharmaceuticals Limited
Open Chart
₹2,411.20
-0.16%
Today High / Low ₹2,411.20 / ₹2,411.20
52W High / Low ₹2,537.60 / ₹1,792.60
Trend Screener Score 77%  |  Very Strong Bullish

GLENMARK Trend Matrix

Monthly Trend Bullish / Sup.. - ₹2,256.40
Weekly Trend Bullish / Sup.. - ₹2,315.10
Daily Trend Bearish / Res.. - ₹2,445.90
Hourly Trend Bearish / Res.. - ₹2,420.20
15M Trend Bullish / Sup.. - ₹2,409.00
CMP vs S/R YES

RSI Momentum Values

Monthly RSI 67.70
Weekly RSI 60.80
Daily RSI 53.71

Moving Average Confluence (SMA)

SMA 200 ₹2,178.43
SMA 100 ₹2,291.18
SMA 50 ₹2,316.75
SMA 20 ₹2,411.48
SMA 10 ₹2,449.42
Overall Trend: Overall trend is very strong, with buying interest visible across multiple timeframes. Momentum and price action point to a healthy uptrend.

Momentum: RSI is around 60.74, which shows buying momentum is still healthy. Lower timeframes are sending mixed signals, pointing to some short-term choppiness.

Moving Averages: Price is sitting above most major moving averages, showing that the overall trend is still positive. However, the price is still above the 200-day SMA, which keeps the long-term trend positive.

Key Levels: The next major support is near ₹2,256.40. The nearest support is around ₹2,315.10. Today's range has been between ₹2,411.20 and ₹2,411.20. The stock is trading in the upper part of its 52-week range, which reflects good long-term strength.

Trend Summary: Very Strong Bullish. The overall trend looks positive. As long as the stock holds its key support levels, the uptrend can continue.
Market Capitalisation See Ratios Below ↓
Key Statements See Ratios Below ↓

About Glenmark Pharmaceuticals

Glenmark Pharmaceuticals Limited develops, manufactures and markets generic, specialty and over-the-counter pharmaceutical products in India and international markets. Its portfolio covers therapeutic areas including dermatology, respiratory care, oncology, immunology, cardiology, diabetes, pain management, gastroenterology and anti-infectives. The company develops products across oral, injectable, topical and respiratory dosage forms and also maintains a pipeline of specialty and biologic drug candidates. Incorporated in 1977, Glenmark Pharmaceuticals is based in Mumbai, India.

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic Website: Official Website

Similar Stocks (NIFTY 200 Peers)

Glenmark Pharmaceuticals Limited (Glenmark Pharmaceuticals) Share Price & Technical Analysis

Track the latest Glenmark Pharmaceuticals Limited share price along with important technical indicators in one place. This page provides a quick overview of the stock's current trend, momentum, and key price levels without switching between multiple charts.

You can check the live market price, Monthly, Weekly, Daily and Intraday trends, RSI values, Moving Averages (SMA), support & resistance levels, and the stock's 52-week high and low to better understand its overall market position.

Trend Screener automatically updates market data throughout trading hours, helping traders and investors stay informed with the latest technical analysis and trend information for 250+ NSE stocks.

Glenmark Pharmaceuticals Limited (Glenmark Pharmaceuticals) Technical Analysis Overview

This page brings together the most important technical indicators for Glenmark Pharmaceuticals Limited in one place. Instead of checking multiple charts, you can quickly review the stock's price action, trend, momentum, and key support and resistance levels from a single dashboard.

Whether you are an intraday trader, swing trader, or long-term investor, this page helps you quickly understand the current technical picture of Glenmark Pharmaceuticals before making your own investment decisions.

Disclaimer: TrendScreener.in is an educational stock analysis platform and is not a SEBI-registered Research Analyst or Investment Advisor. The information on this page is generated using technical indicators and market data and should not be considered as investment advice or buy/sell recommendations. Please do your own research before investing.